FDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decadesFDA approves Bristol Myers Squibb’s schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.